Page last updated: 2024-10-25

deferoxamine and Adenocarcinoma of Lung

deferoxamine has been researched along with Adenocarcinoma of Lung in 1 studies

Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.

Adenocarcinoma of Lung: A carcinoma originating in the lung and the most common lung cancer type in never-smokers. Malignant cells exhibit distinct features such as glandular epithelial, or tubular morphology. Mutations in KRAS, EGFR, BRAF, and ERBB2 genes are associated with this cancer.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kuang, Y1
Guo, W1
Ling, J1
Xu, D1
Liao, Y1
Zhao, H1
Du, X1
Wang, H1
Xu, M1
Song, H1
Wang, T1
Jing, B1
Li, K1
Hu, M1
Wu, W1
Deng, J1
Wang, Q1

Other Studies

1 other study available for deferoxamine and Adenocarcinoma of Lung

ArticleYear
Iron-dependent CDK1 activity promotes lung carcinogenesis via activation of the GP130/STAT3 signaling pathway.
    Cell death & disease, 2019, 04-01, Volume: 10, Issue:4

    Topics: A549 Cells; Adaptor Proteins, Signal Transducing; Adenocarcinoma of Lung; Animals; Carcinogenesis; C

2019